Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes

J Am Coll Cardiol. 2018 Sep 4;72(10):1177-1179. doi: 10.1016/j.jacc.2018.06.042.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Pain / etiology
  • Body Mass Index
  • Cardiovascular Diseases / epidemiology
  • Case-Control Studies
  • Drug Resistance
  • Glycated Hemoglobin / analysis
  • Humans
  • Hyperlipoproteinemia Type I / diagnosis*
  • Hyperlipoproteinemia Type I / drug therapy
  • Hyperlipoproteinemia Type I / epidemiology
  • Hypolipidemic Agents / therapeutic use
  • Middle Aged
  • Ohio / epidemiology
  • Pancreatitis / etiology
  • Prevalence
  • Retrospective Studies
  • Triglycerides / blood

Substances

  • Glycated Hemoglobin A
  • Hypolipidemic Agents
  • Triglycerides
  • hemoglobin A1c protein, human

Supplementary concepts

  • Familial hyperchylomicronemia syndrome